Björn Vandewalle

Vice Director, Science & Innovation
Exigo Consultores, Lisbon, Portugal

Presentation(s):

• PB0193 - Dose optimization for prophylaxis using a pharmacokinetic model for factor IX products in severe hemophilia B

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM